WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
www.bms.com
.
Bristol-Myers Squibb RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category Bristol-Myers Squibb
Title
Published Date
Bristol-Myers Squibb reports fourth quarter and full year 2014 financial results
27 January 2015
Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration
05 January 2015
Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India
03 December 2014
Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration
25 November 2014
Bristol-Myers Squibb to construct a new large-scale biologics manufacturing facility in Ireland
14 November 2014
Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy
28 October 2014
Bristol-Myers Squibb and Pfizer announce charitable donations of more than $1 million to support cardiovascular education
22 September 2014
Allied Minds and Bristol-Myers Squibb form new enterprise
07 August 2014
Bristol-Myers Squibb reports second quarter 2014 financial results
25 July 2014
Bristol-Myers Squibb and Syngene International extend research collaboration
04 June 2014
Bristol-Myers Squibb ranks first on 2014 Best Corporate Citizens List
24 April 2014
Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement
17 March 2014
Bristol-Myers Squibb announces charitable donation of $1 million
04 March 2014
Bristol-Myers Squibb completes previously announced sale of global diabetes business to AstraZeneca
03 February 2014
Bristol-Myers Squibb Reports fourth quarter and full year 2013 financial results
26 January 2014
AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides $5 million grant for American Diabetes Association's Pathway to Stop Diabetes
16 January 2014
Bristol-Myers Squibb to sell its global diabetes business
19 December 2013
Bristol-Myers Squibb Foundation marks World Diabetes Day with four grants addressing link between diabetes, depression and distress
14 November 2013
Bristol-Myers Squibb announces changes in its senior management team
13 November 2013
Bristol-Myers Squibb reports third quarter 2013 financial results
23 October 2013
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Business & Industry
GSK completes acquisition of Sierra Oncology
Pfizer and BioNTech announce new agreement with U.S. government to provide additional doses of COVID-19 vaccine
Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta® (ofatumumab) had no evidence of disease activity (NEDA-3)
Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron
Research & Development
Researchers discover new leukemia-killing compounds
Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by researchers
Biomarkers found that could be drug targets against a deadly form of brain cancer
COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure
Novel drug combo activates natural killer cell immunity to destroy cancer cells
Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants
A new technology offers treatment for HIV infection through a single injection
Conferences & Events
New approach to treatment of deadly kidney cancer
SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
SMi's 22nd Annual Pain Therapeutics Conference
SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
FDA approves first systemic treatment for alopecia areata
FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
FDA limits use of Janssen COVID-19 vaccine to certain individuals
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
FDA approves first generic of Symbicort to treat asthma and COPD
You are here:
Home
Bristol-Myers Squibb